Veracyte Inc (VCYT)

Total asset turnover

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue (ttm) US$ in thousands 479,129 463,393 445,764 425,331 399,579 375,473 361,051 343,149 328,633 311,175 296,536 283,575 268,353 250,594 219,514 186,714 157,465 123,064 117,483 112,677
Total assets US$ in thousands 1,344,100 1,315,410 1,300,040 1,275,020 1,234,330 1,200,070 1,137,820 1,124,940 1,161,110 1,157,120 1,156,420 1,125,960 1,144,200 1,173,590 1,187,820 1,186,360 1,027,440 1,025,140 457,163 454,151
Total asset turnover 0.36 0.35 0.34 0.33 0.32 0.31 0.32 0.31 0.28 0.27 0.26 0.25 0.23 0.21 0.18 0.16 0.15 0.12 0.26 0.25

June 30, 2025 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $479,129K ÷ $1,344,100K
= 0.36

The analysis of Veracyte Inc.'s total asset turnover ratio over the period from September 2020 to June 2025 indicates a consistent upward trend. Initially, the ratio stood at approximately 0.25 as of September 30, 2020, and showed steady incremental increases throughout subsequent periods, reaching approximately 0.36 by June 2025.

This gradual rise suggests an improvement in the company's efficiency in utilizing its assets to generate revenue. Specifically, the ratio's progression from near 0.25 to over 0.30 demonstrates that Veracyte Inc. has been increasingly effective in converting its asset base into sales. The consistent growth over multiple quarters indicates a positive trajectory in operational efficiency, possibly driven by expanded sales volume, increased asset utilization, or both.

The trend reflects a strengthening of asset productivity, which can be interpreted as a favorable development for the company's operational management and overall financial health. The steady increase across quarters diminishes the likelihood of short-term anomalies and points toward sustained or improving asset management strategies during this period.

In summary, Veracyte Inc.'s total asset turnover has demonstrated a consistent upward trajectory over the specified period, highlighting enhanced efficiency in asset utilization to generate revenue.